BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7632028)

  • 21. Questioning the cardioprotective action of hormone replacement therapy in postmenopausal women.
    Mascitelli L; Goldstein MR; Pezzetta F
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):657-8. PubMed ID: 19424079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postmenopausal estrogen and cardiovascular disease.
    Stampfer MJ; Grodstein F; Bechtel S
    Contemp Intern Med; 1994 Sep; 6(9):47-56, 59. PubMed ID: 10150308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Secondary prevention in coronary diseases. Viewpoint of the gynecological endocrinologist].
    Hänggi W
    Praxis (Bern 1994); 1997 Jan; 86(5):145-9. PubMed ID: 9064732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone replacement therapy. Indications, benefits and risk.
    Davis S
    Aust Fam Physician; 1999 May; 28(5):437-45. PubMed ID: 10376367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Postmenopausal hormone replacement and cardiovascular disease].
    Oian P; Aune B
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):193-6. PubMed ID: 8430399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HRT and the primary prevention of cardiovascular disease.
    Stevenson JC
    Maturitas; 2007 May; 57(1):31-4. PubMed ID: 17383835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hormone replacement therapy and cardiovascular risk].
    Maffei S; De Caterina R
    G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of estradiol valerate and dienogest combination on serum homocysteine levels in postmenopausal women: a clinical trial.
    Pirimoglu ZM; Aygun E; Dansuk R; Kucukercan I; Unal O; Turan C
    Gynecol Endocrinol; 2005 Sep; 21(3):185-8. PubMed ID: 16335913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer.
    Vassilopoulou-Sellin R; Theriault RL
    J Natl Cancer Inst Monogr; 1994; (16):153-9. PubMed ID: 7999459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Social medicine aspects of pre- and postmenopause].
    Schmeiser-Rieder A; Concin H; Schwarz B; Kunze M
    Wien Med Wochenschr; 1995; 145(14):331-3. PubMed ID: 7483647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular disease, menopause, and the influence of hormone replacement therapy.
    Lobo RA
    Prog Clin Biol Res; 1989; 320():313-32. PubMed ID: 2690141
    [No Abstract]   [Full Text] [Related]  

  • 37. [Estrogens and cardiovascular diseases in the postmenopause].
    Riedel M; Rafflenbeul W
    Dtsch Med Wochenschr; 1992 Jul; 117(31-32):1205-11. PubMed ID: 1644017
    [No Abstract]   [Full Text] [Related]  

  • 38. Uncertainty about postmenopausal estrogen. Time for action, not debate.
    Goldman L; Tosteson AN
    N Engl J Med; 1991 Sep; 325(11):800-2. PubMed ID: 1870653
    [No Abstract]   [Full Text] [Related]  

  • 39. Menopause and the Heart.
    Nkonde-Price C; Bender JR
    Endocrinol Metab Clin North Am; 2015 Sep; 44(3):559-64. PubMed ID: 26316243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How much of the cardioprotective effect of postmenopausal estrogens is real?
    Vandenbroucke JP
    Epidemiology; 1995 May; 6(3):207-8. PubMed ID: 7619923
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.